Table 4. . Seroprevalence of antibodies against SARS-CoV-2 stratified by age group and sex.

	Overall cohort†		Males‡		Females‡
	Count	Seropositive (%)	Count	Seropositive (%)	Count	Seropositive (%)
Overall	738	5.6 (5.2–6)	340	5.3 (4.7–5.8)	398	5.9 (5.4–6.5)
Age (years)
0–14	67	13 (10.2–16.2)	28	11.1 (7.5–15.6)	39	14.8 (10.8–19.7)
15–18	28	6.1 (4.1–8.7)	14	6.4 (3.6–10.5)	14	5.9 (3.2–9.6)
19–65	539	5.6 (5.1–6.1)	248	5.3 (4.7–6)	291	5.9 (5.2–6.6)
>65	104	4 (3.3–4.8)	50	3.8 (2.8–5)	54	4.2 (3.2–5.5)

^†Data are reported as absolute frequency (percentage with respect to overall cohort and corresponding age stratum of overall cohort reported in Table 2).

^‡Data are reported as absolute frequency (percentage with respect to overall cohort and corresponding age stratum of overall cohort reported in Table 2 divided by sex).

SARS-CoV-2: SARS coronavirus 2.